Nathalie Johnson, M.D., PhD

Dr. Nathalie Johnson is an associate professor in the departments of Medicine and Oncology at McGill University. She performs translational and clinical research at the Jewish General Hospital (JGH) since 2010. She established a lymphoma tumor bank that she shares with other investigators to advance biomedical research in Quebec and Canada. Her translational research focuses on identifying mechanisms of therapeutic resistance to conventional and novel therapies, including immunotherapy. This is funded by numerous agencies including CCSRI and CIHR. She is also the primary investigator of several clinical trials that test novel therapies in patients with newly diagnosed or relapsed lymphoma. She has been the program director of the Clinical Investigator Program at McGill University since 2018.